Nevro Corp Stock Current Valuation
| NVRO Stock | USD 5.77 0.01 0.17% |
Valuation analysis of Nevro Corp helps investors to measure Nevro Corp's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of the 23rd of March 2025, Enterprise Value Over EBITDA is likely to drop to -2.45. In addition to that, Enterprise Value Multiple is likely to drop to -2.45. Fundamental drivers impacting Nevro Corp's valuation include:
Overvalued
Today
Please note that Nevro Corp's price fluctuation is relatively risky at this time. Calculation of the real value of Nevro Corp is based on 3 months time horizon. Increasing Nevro Corp's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Nevro Corp is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nevro Stock. However, Nevro Corp's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.77 | Real 5.16 | Target 5.6 | Hype 5.77 | Naive 5.72 |
The intrinsic value of Nevro Corp's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Nevro Corp's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Nevro Corp helps investors to forecast how Nevro stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nevro Corp more accurately as focusing exclusively on Nevro Corp's fundamentals will not take into account other important factors: Nevro Corp Company Current Valuation Analysis
Nevro Corp's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Nevro Corp Current Valuation | 180.04 M |
Most of Nevro Corp's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nevro Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Nevro Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Nevro Corp is extremely important. It helps to project a fair market value of Nevro Stock properly, considering its historical fundamentals such as Current Valuation. Since Nevro Corp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Nevro Corp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Nevro Corp's interrelated accounts and indicators.
Click cells to compare fundamentals
Nevro Current Valuation Historical Pattern
Today, most investors in Nevro Corp Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Nevro Corp's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Nevro Corp current valuation as a starting point in their analysis.
Nevro Corp Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Nevro Corp has a Current Valuation of 180.04 M. This is 98.75% lower than that of the Health Care Equipment & Supplies sector and 98.55% lower than that of the Health Care industry. The current valuation for all United States stocks is 98.92% higher than that of the company.
Nevro Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nevro Corp's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nevro Corp could also be used in its relative valuation, which is a method of valuing Nevro Corp by comparing valuation metrics of similar companies.Nevro Corp is currently under evaluation in current valuation category among its peers.
Nevro Corp Current Valuation Drivers
We derive many important indicators used in calculating different scores of Nevro Corp from analyzing Nevro Corp's financial statements. These drivers represent accounts that assess Nevro Corp's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Nevro Corp's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 5.8B | 2.8B | 1.4B | 774.3M | 138.0M | 131.1M | |
| Enterprise Value | 6.1B | 3.0B | 1.5B | 891.9M | 294.6M | 279.9M |
Nevro Corp ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Nevro Corp's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Nevro Corp's managers, analysts, and investors.Environmental | Governance | Social |
Nevro Fundamentals
| Return On Equity | -0.43 | ||||
| Return On Asset | -0.0995 | ||||
| Profit Margin | (0.28) % | ||||
| Operating Margin | (0.22) % | ||||
| Current Valuation | 180.04 M | ||||
| Shares Outstanding | 38.37 M | ||||
| Shares Owned By Insiders | 2.87 % | ||||
| Shares Owned By Institutions | 97.13 % | ||||
| Number Of Shares Shorted | 1.82 M | ||||
| Price To Earning | (63.38) X | ||||
| Price To Book | 0.96 X | ||||
| Price To Sales | 0.54 X | ||||
| Revenue | 408.52 M | ||||
| Gross Profit | 269.53 M | ||||
| EBITDA | (126.23 M) | ||||
| Net Income | (113.44 M) | ||||
| Cash And Equivalents | 310.82 M | ||||
| Cash Per Share | 8.78 X | ||||
| Total Debt | 251.16 M | ||||
| Debt To Equity | 0.89 % | ||||
| Current Ratio | 6.65 X | ||||
| Book Value Per Share | 6.11 X | ||||
| Cash Flow From Operations | (19.44 M) | ||||
| Short Ratio | 1.14 X | ||||
| Earnings Per Share | (3.06) X | ||||
| Price To Earnings To Growth | (3.13) X | ||||
| Target Price | 6.53 | ||||
| Number Of Employees | 1.1 K | ||||
| Beta | 0.94 | ||||
| Market Capitalization | 221.41 M | ||||
| Total Asset | 553.84 M | ||||
| Retained Earnings | (812.85 M) | ||||
| Working Capital | 373.06 M | ||||
| Current Asset | 282.63 M | ||||
| Current Liabilities | 36.39 M | ||||
| Net Asset | 553.84 M |
About Nevro Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nevro Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nevro Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nevro Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
When determining whether Nevro Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nevro Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nevro Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nevro Corp Stock: Check out Nevro Corp Piotroski F Score and Nevro Corp Altman Z Score analysis. To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nevro Corp. If investors know Nevro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nevro Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.06) | Revenue Per Share | Quarterly Revenue Growth (0.09) | Return On Assets | Return On Equity |
The market value of Nevro Corp is measured differently than its book value, which is the value of Nevro that is recorded on the company's balance sheet. Investors also form their own opinion of Nevro Corp's value that differs from its market value or its book value, called intrinsic value, which is Nevro Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nevro Corp's market value can be influenced by many factors that don't directly affect Nevro Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nevro Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nevro Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nevro Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.